type here...

CATEGORIES

Medication

LATEST

1234Page 1 of 4

TRENDING

EDITORS CHOICE

Psychedelics and Mental Health

Michael Hunter, MD -
THERE IS A GROWING INTEREST IN HALLUCINOGENS, especially regarding their application for psychiatric disorders.

The 50 Most Influential Leaders in Pharmacy 2022 Awards

Medika Life -
Today the Pharmacy Podcast Network announces the winners of the 50 Most Influential Leaders in Pharmacy 2023 Awards. 

The Future of Cardiovascular Disease Prevention: Insights from Drs. Eric Topol and Pradeep Natarajan

Christopher Nial -
While LDL cholesterol remains a crucial target in cardiovascular prevention, it is important to look beyond this traditional marker.

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston -
The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories